rediff News http://www.rediff.com/tags/erbitux India's largest news and entertainment service online.. en-us Tue, 03 May 16 00:27:12 +0000 Tue, 03 May 16 00:27:12 +0000 http://www.rediff.com/push Rediff feeds Copyright: (C) 2009 Rediff.com India Limited. All Rights Reserved. <![CDATA[Soaring cancer drug costs may cripple medicare]]> http://www.rediff.com/money/report/soaring-cancer-drug-costs-may-cripple-medicare/20090129.htm Tue, 03 May 2016 05:57:12 +0530 <![CDATA['India is a growth story for us']]> http://www.rediff.com/money/report/inter/20081014.htm Tue, 03 May 2016 05:57:12 +0530 <![CDATA[Merck to conduct cancer vaccine trials in India]]> http://www.rediff.com/money/report/mer/20061101.htm Tue, 03 May 2016 05:57:12 +0530 <![CDATA[Who could replace Peter Dolan?]]> http://www.rediff.com/money/report/forbes/20060923.htm Tue, 03 May 2016 05:57:12 +0530 <![CDATA[4 hottest biotech firms to watch]]> http://www.rediff.com/money/special/bio/20060125.htm Tue, 03 May 2016 05:57:12 +0530 <![CDATA[Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market to Reach US$25.1 bn by 2023 as Oncology Therapeutics Advance]]> http://pressreleaseping.com/global-high-potency-active-pharmaceutical-ingredient-hpapi-market-reach-us251-bn-2023-oncology Tue, 03 May 2016 05:57:12 +0530 <![CDATA[Lilly Reports FirstQuarter 2016 Results Revises 2016 Financial Guidance]]> http://www.pharmafocusasia.com/pressreleases/lilly-reports-first-quarter-2016-results-revises-2016-financial-guidance Tue, 03 May 2016 05:57:12 +0530 <![CDATA[ Chinese Phase III Study With Erbitux Plus FOLFOX Meets Primary Endpoint]]> http://www.htsyndication.com/htsportal/article/Merck%3A-Chinese-Phase-III-Study-With-Erbitux-Plus-FOLFOX-Meets-Primary-Endpoint/12729434 Tue, 03 May 2016 05:57:12 +0530 <![CDATA[ study]]> https://in.news.yahoo.com/bristol-myers-opdivo-extends-survival-head-neck-cancer-133318429--finance.html Tue, 03 May 2016 05:57:12 +0530 <![CDATA[Sysmex Inostics' OncoBEAM RAS CRC test receives CE Mark approval]]> http://www.pharmabiz.com/NewsDetails.aspx?aid=94509&sid=2 Tue, 03 May 2016 05:57:12 +0530